Previous close | 59.70 |
Open | 61.56 |
Bid | 62.00 x 1300 |
Ask | 62.40 x 1300 |
Day's range | 60.28 - 63.80 |
52-week range | 58.93 - 96.12 |
Volume | |
Avg. volume | 3,667,435 |
Market cap | 37.584B |
Beta (5Y monthly) | 1.11 |
PE ratio (TTM) | 26.10 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
IRVINE, Calif., July 24, 2024--Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended June 30, 2024.
IRVINE, Calif., July 24, 2024--Edwards Lifesciences (NYSE: EW) today announced investments that reflect the company’s deep commitment to advancing patient care through structural heart innovation, addressing large unmet patient needs and supporting sustainable long-term growth.
IRVINE, Calif., July 17, 2024--Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended June 30, 2024 after the market closes on Wednesday, July 24, 2024, and will host a conference call at 5:00 p.m. ET that day to discuss those results.